CpG Oligodeoxynucleotides as Vaccine Adjuvants in Primates
- 15 February 2002
- journal article
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 168 (4) , 1659-1663
- https://doi.org/10.4049/jimmunol.168.4.1659
Abstract
Synthetic oligodeoxynucleotides (ODN) containing unmethylated CpG motifs act as immune adjuvants in mice, boosting the humoral and cellular response to coadministered Ags. CpG ODN that stimulate human PBMC are only weakly active in mice. Thus, alternative animal models are needed to monitor the activity and safety of “human” CpG ODN in vivo. This work demonstrates that rhesus macaques recognize and respond to the same CpG motifs that trigger human immune cells. Coadministering CpG ODN with heat-killed Leishmania vaccine provided significantly increased protection of macaques against cutaneous Leishmania infection. These findings indicate that rhesus macaques provide a useful model for studying the in vivo activity of human CpG motifs, and that ODN expressing these motifs act as strong immune adjuvants.Keywords
This publication has 38 references indexed in Scilit:
- Subsets of Human Dendritic Cell Precursors Express Different Toll-like Receptors and Respond to Different Microbial AntigensThe Journal of Experimental Medicine, 2001
- Identification of CpG oligonucleotide sequences with high induction of IFN-α/β in plasmacytoid dendritic cellsEuropean Journal of Immunology, 2001
- From Bugs to Drugs: Therapeutic Immunomodulation with Oligodeoxynucleotides Containing CpG Sequences from Bacterial DNAAntisense and Nucleic Acid Drug Development, 2001
- CpG Oligodeoxynucleotides and Interleukin-12 Improve the Efficacy ofMycobacterium bovisBCG Vaccination in Mice Challenged withM. tuberculosisInfection and Immunity, 2000
- CpG DNA overcomes hyporesponsiveness to hepatitis B vaccine in orangutansVaccine, 2000
- DNA activates human immune cells through a CpG sequence‐dependent mannerImmunology, 1999
- Therapeutic Applications of CpG-Containing OligodeoxynucleotidesAntisense and Nucleic Acid Drug Development, 1998
- CpG‐containing synthetic oligonucleotides promote B and cytotoxic T cell responses to protein antigen: A new class of vaccine adjuvantsEuropean Journal of Immunology, 1997
- Leishmania amazonensis:The Asian Rhesus Macaques (Macaca mulatta) as an Experimental Model for Study of Cutaneous LeishmaniasisExperimental Parasitology, 1996
- CpG motifs in bacterial DNA trigger direct B-cell activationNature, 1995